Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of intrabone single unit cord blood transplantation for hematological malignancies.
Murata M, Maeda Y, Masuko M, Onishi Y, Endo T, Terakura S, Ishikawa Y, Iriyama C, Ushijima Y, Goto T, Fujii N, Tanimoto M, Kobayashi H, Shibasaki Y, Fukuhara N, Inamoto Y, Suzuki R, Kodera Y, Matsushita T, Kiyoi H, Naoe T, Nishida T. Murata M, et al. Among authors: ishikawa y. Cancer Sci. 2017 Aug;108(8):1634-1639. doi: 10.1111/cas.13291. Epub 2017 Jun 29. Cancer Sci. 2017. PMID: 28582607 Free PMC article. Clinical Trial.
Prognostic implication and biological roles of RhoH in acute myeloid leukaemia.
Iwasaki T, Katsumi A, Kiyoi H, Tanizaki R, Ishikawa Y, Ozeki K, Kobayashi M, Abe A, Matsushita T, Watanabe T, Amano M, Kojima T, Kaibuchi K, Naoe T. Iwasaki T, et al. Among authors: ishikawa y. Eur J Haematol. 2008 Dec;81(6):454-60. doi: 10.1111/j.1600-0609.2008.01132.x. Epub 2008 Aug 6. Eur J Haematol. 2008. PMID: 18691253
Mutational analysis of SOS1 gene in acute myeloid leukemia.
Tanizaki R, Katsumi A, Kiyoi H, Kunishima S, Iwasaki T, Ishikawa Y, Kobayashi M, Abe A, Matsushita T, Watanabe T, Kojima T, Kaibuchi K, Kojima S, Naoe T. Tanizaki R, et al. Among authors: ishikawa y. Int J Hematol. 2008 Nov;88(4):460-462. doi: 10.1007/s12185-008-0185-1. Epub 2008 Oct 30. Int J Hematol. 2008. PMID: 18972187 No abstract available.
Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: a report from the BINGO study.
Ishikawa Y, Kiyoi H, Watanabe K, Miyamura K, Nakano Y, Kitamura K, Kohno A, Sugiura I, Yokozawa T, Hanamura A, Yamamoto K, Iida H, Emi N, Suzuki R, Ohnishi K, Naoe T. Ishikawa Y, et al. Cancer Sci. 2010 Oct;101(10):2186-92. doi: 10.1111/j.1349-7006.2010.01643.x. Epub 2010 Jul 1. Cancer Sci. 2010. PMID: 20608939 Free PMC article.
A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis.
Sakai K, Ishikawa Y, Mori Y, Kobayashi M, Iriyama C, Ozawa Y, Suzuki T, Minami Y, Ishikawa K, Kaneda N, Naoe T, Kiyoi H. Sakai K, et al. Among authors: ishikawa k, ishikawa y. Int J Hematol. 2011 Feb;93(2):237-242. doi: 10.1007/s12185-011-0766-2. Epub 2011 Jan 25. Int J Hematol. 2011. PMID: 21264552
3,758 results